A detailed history of Northern Trust Corp transactions in Natera, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 537,042 shares of NTRA stock, worth $85.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
537,042
Previous 562,898 4.59%
Holding current value
$85.7 Million
Previous $61 Million 11.98%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$97.75 - $129.67 $2.53 Million - $3.35 Million
-25,856 Reduced 4.59%
537,042 $68.3 Million
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $1.78 Million - $2.36 Million
20,921 Added 3.86%
562,898 $61 Million
Q1 2024

May 14, 2024

SELL
$59.21 - $92.9 $185,386 - $290,869
-3,131 Reduced 0.57%
541,977 $49.6 Million
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $421,273 - $702,758
11,219 Added 2.1%
545,108 $34.1 Million
Q3 2023

Nov 13, 2023

BUY
$43.4 - $62.52 $186,229 - $268,273
4,291 Added 0.81%
533,889 $23.6 Million
Q2 2023

Aug 11, 2023

BUY
$47.08 - $55.16 $1.02 Million - $1.19 Million
21,584 Added 4.25%
529,598 $25.8 Million
Q1 2023

May 15, 2023

BUY
$36.57 - $58.29 $747,856 - $1.19 Million
20,450 Added 4.19%
508,014 $28.2 Million
Q4 2022

Feb 13, 2023

BUY
$34.17 - $47.91 $1.78 Million - $2.5 Million
52,126 Added 11.97%
487,564 $19.6 Million
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $726,302 - $1.11 Million
19,667 Added 4.73%
435,438 $19.1 Million
Q2 2022

Aug 12, 2022

BUY
$28.13 - $44.54 $1.23 Million - $1.94 Million
43,648 Added 11.73%
415,771 $14.7 Million
Q1 2022

May 13, 2022

SELL
$30.32 - $91.33 $571,319 - $1.72 Million
-18,843 Reduced 4.82%
372,123 $15.1 Million
Q4 2021

Feb 08, 2022

SELL
$86.26 - $119.0 $1.23 Million - $1.69 Million
-14,209 Reduced 3.51%
390,966 $36.5 Million
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $1.31 Million - $1.65 Million
13,085 Added 3.34%
405,175 $45.2 Million
Q2 2021

Aug 13, 2021

SELL
$86.05 - $119.72 $39.6 Million - $55.1 Million
-460,206 Reduced 54.0%
392,090 $44.5 Million
Q1 2021

May 12, 2021

SELL
$91.47 - $124.36 $15.1 Million - $20.5 Million
-164,970 Reduced 16.22%
852,296 $86.5 Million
Q4 2020

Feb 11, 2021

BUY
$66.66 - $111.74 $2.69 Million - $4.51 Million
40,367 Added 4.13%
1,017,266 $101 Million
Q3 2020

Nov 16, 2020

SELL
$45.89 - $72.67 $744,152 - $1.18 Million
-16,216 Reduced 1.63%
976,899 $70.6 Million
Q2 2020

Aug 14, 2020

BUY
$26.36 - $49.86 $3.08 Million - $5.83 Million
116,975 Added 13.35%
993,115 $49.5 Million
Q1 2020

May 14, 2020

BUY
$17.27 - $40.17 $696,050 - $1.62 Million
40,304 Added 4.82%
876,140 $26.2 Million
Q4 2019

Feb 14, 2020

BUY
$32.1 - $40.4 $1.83 Million - $2.3 Million
56,942 Added 7.31%
835,836 $28.2 Million
Q3 2019

Nov 13, 2019

BUY
$25.38 - $34.89 $6.91 Million - $9.5 Million
272,406 Added 53.78%
778,894 $25.5 Million
Q2 2019

Aug 13, 2019

BUY
$17.75 - $27.58 $1.28 Million - $1.99 Million
72,279 Added 16.65%
506,488 $14 Million
Q1 2019

May 13, 2019

BUY
$11.34 - $20.62 $43,296 - $78,727
3,818 Added 0.89%
434,209 $8.95 Million
Q4 2018

Feb 12, 2019

BUY
$12.32 - $24.38 $57,977 - $114,732
4,706 Added 1.11%
430,391 $6.01 Million
Q3 2018

Nov 14, 2018

BUY
$18.82 - $28.96 $1.12 Million - $1.72 Million
59,497 Added 16.25%
425,685 $10.2 Million
Q2 2018

Sep 18, 2018

SELL
$8.79 - $19.98 $28,391 - $64,535
-3,230 Reduced 0.87%
366,188 $6.89 Million
Q2 2018

Aug 14, 2018

SELL
$8.79 - $19.98 $54,990 - $124,994
-6,256 Reduced 1.67%
369,418 $6.95 Million
Q1 2018

May 09, 2018

BUY
$9.0 - $11.95 $48,852 - $64,864
5,428 Added 1.47%
375,674 $3.48 Million
Q4 2017

Feb 14, 2018

BUY
$8.99 - $14.31 $99,456 - $158,311
11,063 Added 3.08%
370,246 $3.33 Million
Q3 2017

Nov 13, 2017

BUY
$8.02 - $13.33 $2.88 Million - $4.79 Million
359,183
359,183 $4.63 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.5B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.